What is D2 radical gastrectomy for gastric cancer

Radical gastrectomy for gastric cancer D2 is a radical surgery for advanced gastric cancer. For patients with gastric cancer, if all lymph nodes at the first station are cleaned, it is called D1 radical gastrectomy. If all lymph nodes at the second station are cleaned, it is called D2 radical gastrectomy. It has certain advantages in treatment, but it can only be performed after all examinations and doctors have made judgments. Not everyone is suitable for this treatment.

Symptoms of stomach cancer

There are no obvious symptoms in the early stage of gastric cancer. Even if there are symptoms, there are no specific symptoms of indigestion. Usually, there are upper abdominal discomfort, loss of appetite, etc., which are often not taken seriously and delayed in diagnosis. Therefore, the clinical progress of gastric cancer is seen. The common manifestations of gastric cancer are upper abdominal pain, lack of sales anemia, early upper abdominal pain, and the degree is not upper abdominal discomfort. It worsens after eating, and then the pain is hidden. When indigestion or upper abdominal pain occurs, general drug treatment is ineffective, and gastroscopy must be performed. Gastric cancer is the most common malignant tumor in the digestive system, and the incidence rate may be the highest in both urban and rural areas.

What are the classifications of gastric cancer?

The most common type of early gastric cancer is adenocarcinoma. It should be emphasized that once a patient has this condition, he should not miss the opportunity for surgical treatment and must go to a regular hospital for active surgical treatment, because the 5-year survival rate of patients with early gastric cancer will be particularly high after active surgical treatment, so it should be given enough attention. For patients with early gastric cancer, the most common type is adenocarcinoma. According to the classification of histopathology, gastric cancer can be divided into squamous adenocarcinoma, squamous adenocarcinoma, adenocarcinoma and carcinoid.